Rare diseases
Investigational molecules
Locations
Back to Germany262 clinical trials in Bochum, Germany across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Efficacy and Safety of Olatorepatide in Adults with Overweight or Obesity and Type 2 Diabetes
GermanyEfficacy and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Face and Neck Atopic Dermatitis
GermanyGermanyPhase 3 Open‑Label Extension Study of Long‑Term Safety and Efficacy of Rozanolixizumab in Adults with Ocular Myasthenia Gravis
GermanyA Phase 3 Randomized Study of Rozanolixizumab for Safety and Efficacy in Adults with Ocular Myasthenia Gravis
GermanyA study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease
GermanyStudy on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis
GermanyEvaluating mezagitamab in adults with late antibody-mediated rejection after kidney transplant
GermanyStudy of Orforglipron in Overweight Adults at Risk of Developing Obesity‑Related Complications or Class 1 Obesity
GermanyPetosemtamab versus cetuximab plus drug combination as first‑line treatment for adults with metastatic left‑sided colorectal cancer
GermanyStudy of Once‑Weekly Eloralintide (LY3841136 Sodium) in Adults with Obesity or Overweight, Type 2 Diabetes, and High Cardiovascular Risk
GermanyEvaluation of Long-Term Efficacy and Safety of Tirzepatide Versus Intensified Conventional Care in Early Treatment of Type 2 Diabetes in Adults
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on skin conditions, including studies for cutaneous lupus erythematosus, hidradenitis suppurativa, and plaque psoriasis. Novel therapeutic approaches are being evaluated to improve treatment outcomes for patients with chronic skin disorders.
Multiple studies are investigating new medications for moderate to severe cases of these conditions.
Innovative research in cancer treatment, particularly focusing on colorectal cancer, pancreatic cancer, gastric cancer, and non-small cell lung cancer. These trials are evaluating targeted therapies and combination treatments.
New therapeutic approaches combining immunotherapy with targeted treatments are being studied.
Studies focusing on heart failure prevention and chronic kidney disease management. Research includes innovative combination therapies and preventive approaches for high-risk patients.
Trials are evaluating new treatment combinations to improve patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
